应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
休市中 12-05 16:09:08
7.710
+0.060
+0.78%
最高
7.710
最低
7.530
成交量
5,369万
今开
7.620
昨收
7.650
日振幅
2.35%
总市值
888.35亿
流通市值
888.35亿
总股本
115.22亿
成交额
4.10亿
换手率
0.47%
流通股本
115.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
石药集团(01093):GLP-1/GIP受体双偏向性激动多肽注射液在美国获临床试验批准
智通财经 · 12-05 18:55
石药集团(01093):GLP-1/GIP受体双偏向性激动多肽注射液在美国获临床试验批准
CSPC Pharmaceutical 获得美国临床试验批准 - Glp-1/Gip 受体双效激动剂肽注射剂(Syh2069 注射剂)
美股速递 · 12-05 18:55
CSPC Pharmaceutical 获得美国临床试验批准 - Glp-1/Gip 受体双效激动剂肽注射剂(Syh2069 注射剂)
一周内,3款国产新药临床试验申请已获FDA批准
动脉网 · 12-05 11:36
一周内,3款国产新药临床试验申请已获FDA批准
12月4日港股药品及生物科技行业沽空数据盘点,药明生物、三生制药、石药集团沽空金额位居行业前三
证券之星APP · 12-04 18:06
12月4日港股药品及生物科技行业沽空数据盘点,药明生物、三生制药、石药集团沽空金额位居行业前三
每日卖空追踪 | 石药集团 12月04日卖空量成交789.2万股,卖空比例为7.07%
市场透视 · 12-04 16:30
每日卖空追踪 | 石药集团 12月04日卖空量成交789.2万股,卖空比例为7.07%
决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!
智通财经 · 12-03 19:21
决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!
石药集团(01093):选择性5-HT2A受体激动剂在美国获临床试验批准
智通财经 · 12-03 18:34
石药集团(01093):选择性5-HT2A受体激动剂在美国获临床试验批准
石药集团 - 一种选择性5-Ht2a受体激动剂(Syh2056片)在美国获得临床试验批准
美股速递 · 12-03 18:32
石药集团 - 一种选择性5-Ht2a受体激动剂(Syh2056片)在美国获得临床试验批准
【券商聚焦】国信证券:港股短线的调整为2026年赢得空间
金吾财讯 · 12-03 11:09
【券商聚焦】国信证券:港股短线的调整为2026年赢得空间
石药集团12月02日主力净流出356.3万元 散户资金买入
市场透视 · 12-02
石药集团12月02日主力净流出356.3万元 散户资金买入
石药集团(01093)2025年11月股份变动月报表:股本维持稳定
公告速递 · 12-01
石药集团(01093)2025年11月股份变动月报表:股本维持稳定
每日卖空追踪 | 石药集团 12月01日卖空量成交853.6万股,卖空比例为9.19%
市场透视 · 12-01
每日卖空追踪 | 石药集团 12月01日卖空量成交853.6万股,卖空比例为9.19%
智通港股通资金流向统计(T+2)|12月1日
智通财经 · 12-01
智通港股通资金流向统计(T+2)|12月1日
中国创新药BD热潮背后的法律风险隐忧
DoNews · 11-28
中国创新药BD热潮背后的法律风险隐忧
每日卖空追踪 | 石药集团 11月27日卖空量成交1525.6万股,卖空比例为21.57%
市场透视 · 11-27
每日卖空追踪 | 石药集团 11月27日卖空量成交1525.6万股,卖空比例为21.57%
石药集团11月27日获主力加仓1544.9万元
市场透视 · 11-27
石药集团11月27日获主力加仓1544.9万元
CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批
制药网 · 11-27
CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批
石药集团(01093):重组全人源抗Act RIIA / IIB单克隆抗体药物(JMT206)在中国获临床试验批准
智通财经 · 11-26
石药集团(01093):重组全人源抗Act RIIA / IIB单克隆抗体药物(JMT206)在中国获临床试验批准
石药集团 - 重组全人源抗Actriia/Iib单克隆抗体(Jmt206)获得NMPA临床试验批准
美股速递 · 11-26
石药集团 - 重组全人源抗Actriia/Iib单克隆抗体(Jmt206)获得NMPA临床试验批准
11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三
证券之星APP · 11-26
11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三
加载更多
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":7.71,"timestamp":1764922148002,"preClose":7.65,"halted":0,"volume":53687658,"delay":0,"floatShares":11522000000,"shares":11522000000,"eps":0.4059497461076167,"marketStatus":"休市中","change":0.06,"latestTime":"12-05 16:09:08","open":7.62,"high":7.71,"low":7.53,"amount":410243446,"amplitude":0.023529,"askPrice":7.71,"askSize":664000,"bidPrice":7.7,"bidSize":2252000,"shortable":3,"etf":0,"ttmEps":0.390015317423865,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":7.65,"dividendRate":0.032557,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.668107,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1772035200000,"strike":"8.25","timestamp":1764919526877,"price":0.4,"volume":235,"amount":188000,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.3894,"impliedVolPercentile":0.2154},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2589896048","title":"石药集团(01093):GLP-1/GIP受体双偏向性激动多肽注射液在美国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589896048","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589896048?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:55","pubTimestamp":1764932156,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的GLP-1/GIP受体双偏向性激动多肽注射液(该产品)已获得美国食品药品监督管理局批准,可在美国开展临床试验。该产品有望成为中国首款进入临床阶段的GLP-1/GIP受体双偏向激动剂,可选择性激活cAMP通路,显着降低β-arrestin募集,从而减少受体内吞及脱敏,提高药效和效果持续性。非人灵长类重复给药毒理研究显示,该产品耐受性良好,未观察到任何呕吐及胃肠道不良反应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4144","BK4590","LU2039709279.SGD","IE00B543WZ88.USD","LU0315179316.USD","IE0008368742.USD","SG9999004220.SGD","LU1226287792.SGD","GLP","LU0067412154.USD","LU0140636845.USD","LU1226288170.HKD","LU1951186391.HKD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1807302812.USD","01093","LU1226287529.USD","IE00B031HY20.USD","LU1813983027.USD","LU1152091754.HKD","LU1960683339.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1521","LU1008478684.HKD","LU1993786604.SGD","LU1226287875.USD","LU0880133367.SGD","IE0008369823.USD","LU0314109678.HKD","LU0501845795.SGD","LU1226288253.USD","LU0072913022.USD","HK0000165453.HKD","BK1515","IE00B5MMRT66.SGD","BK1191","LU1328277881.USD"],"gpt_icon":0},{"id":"1131615331","title":"CSPC Pharmaceutical 获得美国临床试验批准 - Glp-1/Gip 受体双效激动剂肽注射剂(Syh2069 注射剂)","url":"https://stock-news.laohu8.com/highlight/detail?id=1131615331","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131615331?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:55","pubTimestamp":1764932116,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical 获得美国临床试验批准 - Glp-1/Gip 受体双效激动剂肽注射剂(Syh2069 注射剂)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","SG9999004220.SGD","LU1008478684.HKD","LU2039709279.SGD","BK1521","LU0315179316.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","LU0501845795.SGD","BK1191","IE00B031HY20.USD","LU1813983027.USD","LU0326950275.SGD","LU1226288170.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1993786604.SGD","LU1960683339.HKD","LU0072913022.USD","HK0000165453.HKD","LU0314109678.HKD","BK1515","IE0008369823.USD","LU1951186391.HKD","LU1152091754.HKD","LU1226287792.SGD","LU1807302812.USD","IE0008368742.USD","LU1226288253.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1328277881.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1226287529.USD"],"gpt_icon":0},{"id":"2589858867","title":"一周内,3款国产新药临床试验申请已获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589858867","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589858867?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:36","pubTimestamp":1764905760,"startTime":"0","endTime":"0","summary":"近年来中国医药产业加速向“全球创新”转型,国产创新药密集申请FDA临床,一周内3款国产新药临床试验申请获FDA批准。中国生物制药TQF3250胶囊获中美批准,拟用于减重,治疗2型糖尿病申请也获NMPA批准,其有望实现更优血糖与体重控制;石药集团SYH2056片获FDA批准在美国开展临床试验,该药为选择性5-HT2A受体激动剂,用于治疗抑郁症,单次给药快速起效且无致幻风险;和誉药业ABSK141获FDA批准,用于治疗携带KRASG12D突变的晚期实体瘤患者,此次获批旨在评估其安全性等。国产创新药闯关FDA,标志着中国创新药产业迈向新阶段,企业管线质量提升,未来几年将是成果密集验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205114715952c07ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205114715952c07ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00B031HY20.USD","LU1008478684.HKD","BK1521","IE0008368742.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1951186391.HKD","LU1152091168.USD","LU1813983027.USD","LU0072913022.USD","LU0315179316.USD","BK1515","LU1226287529.USD","LU1993786604.SGD","LU0314109678.HKD","01093","LU1152091754.HKD","LU0140636845.USD","LU0880133367.SGD","LU1960683339.HKD","01177","IE00BZ08YR35.GBP","LU1807302812.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU2039709279.SGD","HK0000165453.HKD","LU1328277881.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1226288253.USD","IE0008369823.USD","LU1226288170.HKD","LU0501845795.SGD","LU0326950275.SGD","LU0067412154.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2589321578","title":"12月4日港股药品及生物科技行业沽空数据盘点,药明生物、三生制药、石药集团沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2589321578","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589321578?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:06","pubTimestamp":1764842782,"startTime":"0","endTime":"0","summary":"证券之星消息,12月4日港交所披露数据显示,当日港股药品及生物科技行业的159只个股中有79只被沽空,总沽空股数为9208.67万股,总沽空金额为16.44亿元(港元),而当日药品及生物科技行业的总成交金额为116.21亿元(港元),沽空比例为14.14%。从沽空金额来看,药明生物、三生制药、石药集团沽空金额位居行业前三,分别为2.23亿港元、2.03亿港元、1.53亿港元。沽空与卖空含义相同,即在并不持有股票的前提下,通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","IE00BZ08YS42.EUR","LU0417516902.SGD","LU1152091168.USD","LU1328277881.USD","LU1226287792.SGD","LU0326950275.SGD","LU1807302812.USD","LU0856984785.SGD","02269","LU1951186391.HKD","BK1589","LU0456846285.SGD","LU0181495838.USD","BK1161","SG9999004220.SGD","LU2039709279.SGD","LU1226287875.USD","LU0043850808.USD","LU0823426308.USD","LU0456827905.SGD","LU1242518931.SGD","01530","IE0008368742.USD","LU0359201612.USD","LU0140636845.USD","LU1880383366.USD","LU1688375341.USD","LU0516422952.EUR","LU0979878070.USD","LU3063872942.SGD","LU1794554557.SGD","LU0307460666.USD","IE00B5MMRT66.SGD","01093","BK1610","LU0819121731.USD","LU1813983027.USD","LU1226288170.HKD","LU0823426480.USD","LU0880133367.SGD","SG9999002463.SGD","LU1720050803.USD","LU0588546209.SGD","LU1242518857.USD","LU0516422440.USD","HK0000165453.HKD","BK1583","LU0320764599.SGD","LU0327786744.USD"],"gpt_icon":0},{"id":"2589867869","title":"每日卖空追踪 | 石药集团 12月04日卖空量成交789.2万股,卖空比例为7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589867869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589867869?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837020,"startTime":"0","endTime":"0","summary":"石药集团北京时间12月04日,跌0.65%,卖空量成交789.2万股,较上一交易日减少19.78%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163216a7235770&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163216a7235770&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","LU1152091168.USD","LU1328277881.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","LU0314109678.HKD","IE00B543WZ88.USD","LU1807302812.USD","LU1951186391.HKD","IE00B031HY20.USD","IE0008369823.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU2039709279.SGD","LU1226287875.USD","LU0501845795.SGD","LU1226287529.USD","IE0008368742.USD","LU0140636845.USD","LU1226288253.USD","LU1008478684.HKD","LU0072913022.USD","IE00B5MMRT66.SGD","LU0315179316.USD","01093","LU1813983027.USD","LU1152091754.HKD","LU1226288170.HKD","BK1191","LU0067412154.USD","LU0880133367.SGD","BK1521","IE00BZ08YT58.USD","BK1515","LU1993786604.SGD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2588048711","title":"决胜港股升浪・致敬卓越力量,“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048711?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:21","pubTimestamp":1764760876,"startTime":"0","endTime":"0","summary":"2025年12月3日,由国内领先的港美股资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办、财经公关综合服务提供商冬日暖阳 Donova 独家承办的 “第十届智通财经资本市场年会暨上市公司颁奖盛典” 在深圳盛大启幕。荣耀加冕:231 家企业及管理者斩获 25 项年度大奖当晚的颁奖典礼星光熠熠,各项大奖实至名归。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","00136","00300","00867","00020","00267","00460","00826","00798","00003","00777","00451","02279","02380","00305","00363","00666","00992","00017","00999","00875","00861","01093","02525","00135","00656","00382","01070","09678","02121","09699","00384","00302","00855","00699","02498","02627","00884","02419","01833","09878","00512","00960","02256","06160","02556","02142","02511"],"gpt_icon":1},{"id":"2588097017","title":"石药集团(01093):选择性5-HT2A受体激动剂在美国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588097017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588097017?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:34","pubTimestamp":1764758099,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的化药1类新药选择性5-羟色胺2A受体激动剂(该产品)已获得美国食品药品监督管理局批准,可在美国开展临床试验。该产品为一种选择性5-HT2A受体激动剂,通过激活该受体改善抑郁障碍患者的疾病状态,单次给药即可快速起效,药效持久,且不产生致幻风险。本次获批的临床适应症为用于治疗抑郁症。目前,集团已在国内外提交了该产品的多项专利申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093):选择性5-HT2A受体激动剂在美国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288253.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","LU0072913022.USD","LU0315179316.USD","LU1226287875.USD","BK1191","IE00B031HY20.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1152091168.USD","LU2039709279.SGD","LU0140636845.USD","LU1226288170.HKD","LU1226287529.USD","BK1521","LU1226287792.SGD","IE0008368742.USD","LU1951186391.HKD","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU1152091754.HKD","LU1807302812.USD","IE0008369823.USD","BK1515","IE00BZ08YR35.GBP","01093","LU1328277881.USD","LU1008478684.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1813983027.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"1116307655","title":"石药集团 - 一种选择性5-Ht2a受体激动剂(Syh2056片)在美国获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1116307655","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116307655?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:32","pubTimestamp":1764757968,"startTime":"0","endTime":"0","summary":"石药集团 - 一种选择性5-Ht2a受体激动剂(Syh2056片)在美国获得临床试验批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1993786604.SGD","LU0067412154.USD","LU1807302812.USD","HK0000165453.HKD","LU0140636845.USD","IE00B031HY20.USD","BK1515","LU1951186391.HKD","IE00B5MMRT66.SGD","LU0314109678.HKD","LU2039709279.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU1226287529.USD","LU1152091754.HKD","LU1226287875.USD","LU1152091168.USD","01093","LU1328277881.USD","LU0501845795.SGD","IE0008369823.USD","LU1226288253.USD","LU1960683339.HKD","BK1191","IE00BZ08YR35.GBP","LU0880133367.SGD","IE00BZ08YT58.USD","IE0008368742.USD","IE00BZ08YS42.EUR","LU1813983027.USD","SG9999004220.SGD","LU1008478684.HKD","LU1226288170.HKD","BK1521","LU0072913022.USD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2588099335","title":"【券商聚焦】国信证券:港股短线的调整为2026年赢得空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2588099335","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588099335?lang=zh_cn&edition=full","pubTime":"2025-12-03 11:09","pubTimestamp":1764731351,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国信证券研报指,港股短线的调整为2026年赢得空间。但站在布局明年的角度,有不少乐观的理由,包括:1、美联储持续降息将带来流动性的逐步宽松;2、AI 的进步值得期待,26 年有望更加广泛的 AI 应用推出;3、汽车、半导体明年依然有较好的利润增长;4、外卖战有望在 26 年的某个时间趋缓;5、十五五规划落地带来的积极影响。美元指数将在26年初期持续走弱,这有利于新兴市场的估值修复。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970805","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU0633140560.USD","LU1251922891.USD","02121","IE0008369823.USD","LU1961090484.USD","IE00B0169L03.USD","09999","LU0315179316.USD","LU0051755006.USD","LU2399975544.HKD","LU0588546209.SGD","LU2476274720.SGD","BK1583","IE0032834883.USD","01801","LU0320764599.SGD","06181","LU0456827905.SGD","LU0307460666.USD","IE00B97KM107.HKD","00325","LU0611395673.USD","HK0000306701.USD","LU0862451753.SGD","01318","01177","LU0052750758.USD","LU0469268626.HKD","LU0039217434.USD","LU1152091168.USD","HK0000320223.HKD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU1794554557.SGD","LU1226287875.USD","LU1303224171.USD","LU0871576103.HKD","BK1163","LU0106959298.USD","LU0049853897.USD","002736","LU1688375341.USD","BK1609","LU0501845795.SGD","LU1008478684.HKD","LU0348825331.USD","01093"],"gpt_icon":1},{"id":"2588067173","title":"石药集团12月02日主力净流出356.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588067173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588067173?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:16","pubTimestamp":1764663360,"startTime":"0","endTime":"0","summary":"12月02日, 石药集团股价跌0.76%,报收7.79元,成交金额5.4亿元,换手率0.60%,振幅1.53%,量比0.66。石药集团今日主力资金净流出356.3万元,上一交易日主力净流入500.8万元。该股近5个交易日上涨0.90%,主力资金累计净流入2747.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3885.6万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162236978b5ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202162236978b5ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","IE0008369823.USD","LU1226287875.USD","LU1813983027.USD","LU0314109678.HKD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","HK0000165453.HKD","LU1226288253.USD","LU0067412154.USD","LU1226287529.USD","IE00B031HY20.USD","LU1152091754.HKD","01093","LU1226288170.HKD","LU1993786604.SGD","LU1807302812.USD","BK1191","BK1521","BK1515","LU0140636845.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1152091168.USD","LU0072913022.USD","LU0326950275.SGD","SG9999004220.SGD","IE00B543WZ88.USD","LU1226287792.SGD","IE0008368742.USD","LU0315179316.USD","LU0880133367.SGD","LU1008478684.HKD","LU0501845795.SGD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"1165010048","title":"石药集团(01093)2025年11月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1165010048","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165010048?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:55","pubTimestamp":1764579358,"startTime":"0","endTime":"0","summary":"石药集团有限公司(01093)于2025年12月1日发布的2025年11月股份变动月报表显示,截至2025年11月30日,公司已发行普通股总数为11,522,451,732股,与上个月持平,期内无新增发行或回购、注销及库藏股变动。\n公司现有一项于2015年12月9日生效的购股权计划,期末称可发行股份期权共1,300,000份,与上月相同,当月并未发生行使、失效或其他变动。截至本月末,若相关期权获行使,最多可发行或从库藏中转让566,101,840股。\n公司同时确认遵守香港联交所《上市规则》及相关法规。本次月报表由公司秘书罗泰安签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"gpt_icon":0},{"id":"2588666038","title":"每日卖空追踪 | 石药集团 12月01日卖空量成交853.6万股,卖空比例为9.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588666038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588666038?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577818,"startTime":"0","endTime":"0","summary":"石药集团北京时间12月01日,跌0.76%,卖空量成交853.6万股,较上一交易日减少32.54%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116321095244785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116321095244785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","LU0072913022.USD","LU0315179316.USD","LU1226287875.USD","BK1191","IE00B031HY20.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1152091168.USD","LU2039709279.SGD","LU0140636845.USD","LU1226288170.HKD","LU1226287529.USD","BK1521","LU1226287792.SGD","IE0008368742.USD","LU1951186391.HKD","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU1152091754.HKD","LU1807302812.USD","IE0008369823.USD","BK1515","IE00BZ08YR35.GBP","01093","LU1328277881.USD","LU1008478684.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1813983027.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"2588169737","title":"智通港股通资金流向统计(T+2)|12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588169737","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588169737?lang=zh_cn&edition=full","pubTime":"2025-12-01 07:31","pubTimestamp":1764545460,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月26日,阿里巴巴-W、泡泡玛特、招商银行南向资金净流入金额位列市场前三,分别净流入15.22 亿、3.85 亿、3.30 亿盈富基金、腾讯控股、恒生中国企业南向资金净流出金额位列市场前三,分别净流出-22.61 亿、-11.82 亿、-8.33 亿在净流入比方面,中国外运、南方东西精选、中远海运港口以73.90%、64.44%、60.69%位列市场前三。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03968","01066","00272","06869","02828","06198","81211","09992","00598","00995","01093","02628","09890","01361","80883","00700","01199","01378","03441","01405","06699","HYDD.SI","01277","HSHD.SI","00639","09979","BYDDY","02883","02469","00003","HSBA.UK","03866","HTCD.SI","HSBC","09988","01882","00941","02380","HBBD.SI","METmain","00005","02800","02562"],"gpt_icon":1},{"id":"2587881731","title":"中国创新药BD热潮背后的法律风险隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2587881731","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587881731?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:17","pubTimestamp":1764314223,"startTime":"0","endTime":"0","summary":"2025年,中国创新药BD出海交易额达1042亿美元,首付款达81亿美元,均超去年全年总和。这些数据反映出中国创新药加速崛起并获得全球主流市场认可。亨利医药造假风波虽尚无定论,但已引发对BD交易潜在诉讼潮的警惕。知情人士称,国内真正精通复杂BD协议的律师不超过10人,导致大量协议可能存在条款漏洞。随着国产创新药持续发展及大药企面临专利悬崖,BD逻辑仍将延续。中国创新药出海始终在解决问题中前行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112815235997844565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112815235997844565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06978","LU2543165471.USD","BK1574","LU1023057109.AUD","BK1161","LU0359201612.USD","LU0359202008.SGD","01276","01093","LU0359201885.HKD"],"gpt_icon":0},{"id":"2586622600","title":"每日卖空追踪 | 石药集团 11月27日卖空量成交1525.6万股,卖空比例为21.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586622600","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586622600?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232216,"startTime":"0","endTime":"0","summary":"石药集团北京时间11月27日,涨1.13%,卖空量成交1525.6万股,较上一交易日减少64.59%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716345797826331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716345797826331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","LU1807302812.USD","SG9999004220.SGD","IE0008369823.USD","LU1226288170.HKD","LU1328277881.USD","LU0140636845.USD","IE00B031HY20.USD","LU1226287792.SGD","LU1152091168.USD","LU0067412154.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1521","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0326950275.SGD","LU0880133367.SGD","LU1226287529.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU0501845795.SGD","LU1226288253.USD","LU0314109678.HKD","LU1813983027.USD","BK1515","LU1008478684.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091754.HKD","LU1951186391.HKD","BK1191","IE0008368742.USD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2586014226","title":"石药集团11月27日获主力加仓1544.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586014226","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586014226?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231338,"startTime":"0","endTime":"0","summary":"11月27日, 石药集团股价涨1.13%,报收8.04元,成交金额5.7亿元,换手率0.61%,振幅2.39%,量比0.56。石药集团今日主力资金净流入1544.9万元,连续4日净流入,上一交易日主力净流入2663.1万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为61.54%,平均涨幅为3.89%。该股近5个交易日上涨3.76%,主力资金累计净流入1.6亿元;近20日主力资金累计净流入1.3亿元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127161832951d4f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127161832951d4f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288170.HKD","IE0008369823.USD","LU1960683339.HKD","LU0315179316.USD","IE00BZ08YR35.GBP","LU1226288253.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287875.USD","HK0000165453.HKD","LU0326950275.SGD","LU1807302812.USD","LU0140636845.USD","LU1226287792.SGD","LU1328277881.USD","LU1993786604.SGD","BK1515","SG9999004220.SGD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1008478684.HKD","LU0314109678.HKD","LU0067412154.USD","LU2039709279.SGD","LU1813983027.USD","LU0880133367.SGD","LU1951186391.HKD","IE00B031HY20.USD","LU1152091168.USD","BK1191","BK1521","IE00B5MMRT66.SGD","LU1226287529.USD","IE0008368742.USD","01093"],"gpt_icon":0},{"id":"2586213258","title":"CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213258","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213258?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:35","pubTimestamp":1764214523,"startTime":"0","endTime":"0","summary":"今年8月启函生物还宣布,其自主研发的通用型双靶点CAR-T细胞产品QT-019B新药临床试验申请已获得美国食品药品监督管理局正式批准。据悉,在CAR-T药物用于治疗系统性红斑狼疮等自免疾病的研发管线上,已有多家国内药企布局。CAR-T疗法以治疗血液肿瘤闻名,如今在自身免疫性疾病领域的突破,是其治疗潜力的又一次拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127113909a714489f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127113909a714489f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01093","02126","BK1583"],"gpt_icon":0},{"id":"2586253499","title":"石药集团(01093):重组全人源抗Act RIIA / IIB单克隆抗体药物(JMT206)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2586253499","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586253499?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:23","pubTimestamp":1764152615,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的重组全人源抗Act RIIA / IIB单克隆抗体药物(该产品)已获中华人民共和国国家药品监督管理局批准,可在中国开展临床试验。同时,该产品亦可协助GLP -1 受体激动剂实现更高质量的减重疗效。本次获批的临床适应症为肥胖或超重合并至少一种体重相关合并症人群的体重管理。临床前研究显示,该产品表现出较高的生物利用度以及良好的疗效和安全性,具有较高的临床开发价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093):重组全人源抗Act RIIA / IIB单克隆抗体药物(JMT206)在中国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0326950275.SGD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1951186391.HKD","LU1813983027.USD","LU1226287875.USD","LU1226288170.HKD","SG9999004220.SGD","LU1152091754.HKD","IE00B543WZ88.USD","LU0140636845.USD","HK0000165453.HKD","LU0314109678.HKD","LU0880133367.SGD","BK1191","IE00B031HY20.USD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287529.USD","IE0008369823.USD","LU0315179316.USD","LU1152091168.USD","LU0072913022.USD","LU1960683339.HKD","BK1515","LU0501845795.SGD","01093","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1521","LU2039709279.SGD","LU1226287792.SGD","LU0067412154.USD","LU1328277881.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"1169675744","title":"石药集团 - 重组全人源抗Actriia/Iib单克隆抗体(Jmt206)获得NMPA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1169675744","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169675744?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:22","pubTimestamp":1764152533,"startTime":"0","endTime":"0","summary":"石药集团 - 重组全人源抗Actriia/Iib单克隆抗体(Jmt206)获得NMPA临床试验批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1191","LU1152091168.USD","LU0067412154.USD","LU0314109678.HKD","LU0501845795.SGD","LU2039709279.SGD","IE00B031HY20.USD","LU1226287875.USD","LU1813983027.USD","LU1960683339.HKD","LU1993786604.SGD","LU1008478684.HKD","LU1807302812.USD","LU1226288170.HKD","LU1951186391.HKD","01093","LU0140636845.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU0315179316.USD","IE00BZ08YR35.GBP","BK1515","LU1152091754.HKD","IE00BZ08YS42.EUR","IE0008368742.USD","LU1226287792.SGD","IE00B543WZ88.USD","LU0326950275.SGD","LU0880133367.SGD","BK1521","LU0072913022.USD","LU1226287529.USD","SG9999004220.SGD","LU1226288253.USD","IE0008369823.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2586295801","title":"11月26日港股药品及生物科技行业沽空数据盘点,药明康德、石药集团、京东健康沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2586295801","media":"证券之星APP","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586295801?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:05","pubTimestamp":1764151554,"startTime":"0","endTime":"0","summary":"证券之星消息,11月26日港交所披露数据显示,当日港股药品及生物科技行业的159只个股中有82只被沽空,总沽空股数为1.43亿股,总沽空金额为24.9亿元(港元),而当日药品及生物科技行业的总成交金额为142.25亿元(港元),沽空比例为17.5%。当日药品及生物科技行业总体涨1.03%。从沽空金额来看,药明康德、石药集团、京东健康沽空金额位居行业前三,分别为4.03亿港元、3.5亿港元、3.37亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126181241a712be4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126181241a712be4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","LU0315179316.USD","SG9999004220.SGD","BK1591","LU0051755006.USD","BK1589","LU0320764599.SGD","LU0326950275.SGD","LU1328277881.USD","02359","BK1515","LU0880133367.SGD","01093","IE00BZ08YT58.USD","LU0072913022.USD","LU0501845795.SGD","86618","LU1226287792.SGD","BK1142","LU1807302812.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU0314109678.HKD","BK1141","LU2125910500.SGD","LU1008478684.HKD","BK1247","HK0000165453.HKD","LU1960683339.HKD","BK1521","SGXZ62798434.SGD","LU1046422090.SGD","LU1152091168.USD","IE00B543WZ88.USD","LU1951186391.HKD","BK1571","IE00B031HY20.USD","BK1576","IE0008368742.USD","LU1226288170.HKD","LU1226287875.USD","IE0008369823.USD","06618","LU1152091754.HKD","LU1226287529.USD","LU0456827905.SGD","LU0052750758.USD","SGXZ86797644.SGD","LU0140636845.USD","LU0067412154.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0419},{"period":"3month","weight":-0.3004},{"period":"6month","weight":-0.1164},{"period":"1year","weight":0.6116},{"period":"ytd","weight":0.6588}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.005459},{"month":2,"riseRate":0.741935,"avgChangeRate":0.096733},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.46875,"avgChangeRate":-0.016116}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}